BELLUS Health TSX BLU
$19.48 -0.02 -0.10%
Today share price
Canada
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.53B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.48B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-0.75
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

78.34M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events BELLUS Health All events
No upcoming events scheduled

Stock chart BELLUS Health

Stock analysis BELLUS Health

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-32.62 -5.01
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
10.37 2.19
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-30.73 0.70
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.02 1.61
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-39.99 -0.10

Price change BELLUS Health per year

2.95$ 9.31$
Min Max

Summary analysis BELLUS Health

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure BELLUS Health

Revenue and net income BELLUS Health

All parameters
Stock news BELLUS Health All news

ADRs End Mostly Higher; Natura & Co., Bellus Health Trade Actively

ADRs End Mostly Higher; Natura & Co., Bellus Health Trade Actively

Toronto Stocks Edge Higher; Bellus Health Surges on GSK Buyout

Toronto Stocks Edge Higher; Bellus Health Surges on GSK Buyout

Bellus Health Toronto-Listed Shares Double on GSK Takeover

Bellus Health Toronto-Listed Shares Double on GSK Takeover

Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss

Bellus Health soars, J&J and BofA climb premarket

Bellus Health Shares Soar Premarket on Takeover by GSK >BLU

Bellus Health Shares Soar Premarket on Takeover by GSK >BLU

Bellus Health Sees Positive Results in Extended-Release Camlipixant Study

Bellus Health Sees Positive Results in Extended-Release Camlipixant Study

Bellus Health stock price target raised to $24 from $20 at Evercore ISI

Bellus Health Shares Drop After Stock Offering Prices

Bellus Health Shares Drop After Stock Offering Prices

Bellus Health Shares Fall After Company Announces Launch of Public Offering

Bellus Health Shares Fall After Company Announces Launch of Public Offering

Bellus Health Shares Rise 54% After Trial for Chronic Cough Treatment Meets Endpoint

Bellus Health Shares Rise 54% After Trial for Chronic Cough Treatment Meets Endpoint

Bellus Health Trial for Chronic Cough Treatment Meets Primary Endpoint

About company BELLUS Health

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.
Address:
Company name: BELLUS Health
Issuer ticker: BLU
Country: Canada
Exchange: TSX
Currency: $
Sector: Healthcare
Industry: Biotechnology
Site:

On which stock exchange are BELLUS Health (BLU) stocks traded?

BELLUS Health (BLU) stocks are traded on TSX.

What is the ticker of BELLUS Health stocks (BLU)?

The stock ticker of BELLUS Health’s stocks or in other words, the code is BLU. The stocks are currently listed on the TSX exchange.

In which sector and industry does BELLUS Health (BLU) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, BELLUS Health (BLU) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are BELLUS Health (BLU) stocks traded?

BELLUS Health (BLU) stocks are traded on the TSX exchange in dollars.

What is the price of BELLUS Health (BLU) stocks today?

The current price of BELLUS Health stocks on 29.04.2024 is 19.48 dollars. per share.

What is the dynamics of BELLUS Health (BLU) stocks from the beginning of the year?

BELLUS Health (BLU) quotes have increased by 0% from the beginning of the year up to 19.48 dollars. per 1 stocks.

How much did BELLUS Health (BLU) stocks increase in апреле 2024?

This month BELLUS Health (BLU) quotes have increased by 0% to 19.48 dollars. per share.

How much are BELLUS Health (BLU) stocks worth?

Today, on October, 29.04.2024 BELLUS Health’s (BLU) stocks cost 19.48 dollars..

What is the market capitalization of BELLUS Health (BLU)?

Capitalization is the market value of BELLUS Health (BLU) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of BELLUS Health (BLU) is estimated at about 1526011792 dollars.